FOI release

Freedom of Information responses from the MHRA - week commencing 9 August 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 9 August 2021

• From: Medicines and Healthcare products Regulatory Agency
• Published: 27 April 2022

Documents

Freedom of Information request on the annual number of UK spontaneous, suspected ADR reports and deaths for flu vaccines for the last ten years (2010 to 2020) for over 65s only (FOI 21/755)

HTML

Freedom of Information request on the number of UK spontaneous, suspected ADR reports and deaths for COVID vaccines for over 65s only (FOI 21/767)

HTML

Freedom of Information request on the IDAP for all current COVID vaccines (FOI 21/806)

HTML

Freedom of Information request on all the reported side effects for all (combined) COVID-19 vaccinations (FOI 21/818)

HTML

Freedom Information request on the breakdown showing how many days following vaccination that each fatality occurred and their age (FOI 21/828)

HTML

Freedom Information request on the number of hospitalisations due to ADRs to COVID vaccines, number of autopsies of the fatalities reported to the Yellow Card system and the current survival rate of the Delta variant of COVID-19 (FOI 21/832)

HTML

Freedom of Information request on SmPC according to our records (FOI 21/853)

HTML

Freedom of Information request (FOI 21-853)

PDF, 17.9 KB, 3 pages

Freedom Information request on the temporary authorisations of the Pfizer/BioNTech, Oxford/AstraZeneca and Moderna vaccines was done through an expedited rolling review

HTML

Freedom Information request on the assessment of the non-clinical data by MHRA and the EMA (FOI 21/866)

HTML

Freedom Information request on the evidence that proves that face coverings prevent transmission (FOI 21/867)

HTML

Freedom of Information request on the temporary authorisations for use of the COVID-19 vaccines in the UK followed a rigorous scientific assessment of all the available evidence of quality, safety and effectiveness (FOI 21/874)

HTML

Freedom of Information request onclarification and the MHRA assessment report Telfast 120 and 180 mg film-coated tablets (PL 04425/0157-0158) (FOI 21/697)

HTML

Freedom of Information request (FOI 21-697-1)

PDF, 2.16 MB, 28 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 9 August 2021

Published 27 April 2022